Search Results

• • 4 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.

  Authors:Neal D. Shore, Fred Saad, Michael S. Cookson, Daniel J. George, Daniel R. Saltzstein, Ronald Tutrone, et al.From:The New England Journal of Medicine (Vol. 382, Issue 23) Peer-Reviewed

  June 4, 202046 words Report

   Citation Only

• Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.

  Authors:Ronald de Wit, Johann de Bono, Cora N. Sternberg, Karim Fizazi, Bertrand Tombal, Christian Wulfing, et al.From:The New England Journal of Medicine (Vol. 381, Issue 26) Peer-Reviewed

  Dec. 26, 201951 words Report

   Citation Only

• Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

  Authors:Matthew R Smith, Fred Saad, Robert Coleman, Neal Shore, Karim Fizazi, Bertrand Tombal, et al.From:The Lancet (Vol. 379, Issue 9810) Peer-Reviewed

  Jan. 7, 2012 Author abstract, Rep...

   Citation Only

• Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization

  Authors:Jean-Luc Gala, Michel Heusterspreute, Sylvain Loric, France Hanon, Bertrand Tombal, Paul Van Cangh, et al.From:Clinical Chemistry (Vol. 44, Issue 3) Peer-Reviewed

  Mar. 19986,390 words Article 1470L

   Citation Only